The "NEW" Oil and Gas Crisis: Lack Of Lithium
We are in a global lithium crisis that's going to get far worse. Just like OPEC and Russia control the price and supply of oil and gas, China has the U.S. in a chokehold when it comes to lithium.
Click here to see how the prices may explode

BIOC Insider Trading

Insider Ownership Percentage: 0.92%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $288.97

Biocept Insider Trading History Chart

This chart shows the insider buying and selling history at Biocept by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Biocept Share Price & Price History

Current Price: $0.76
Price Change: Price Increase of +0.0001 (0.01%)
As of 12/5/2022 06:07 PM ET

This chart shows the closing price history over time for BIOC up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Biocept Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/9/2021David F. HaleDirectorSell71$4.07$288.97View SEC Filing Icon  
6/12/2020David F. HaleDirectorSell1,160$0.55$638.00View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Biocept (NASDAQ:BIOC)

11.21% of Biocept stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at BIOC by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Biocept Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
11/15/2022Vanguard Group Inc.617,610$0.57M0.0%-5.8%3.620%Search for SEC Filing on Google Icon
8/15/2022Millennium Management LLC103,124$97K0.0%N/A0.609%Search for SEC Filing on Google Icon
8/13/2022Renaissance Technologies LLC175,500$0.17M0.0%+50.8%1.037%Search for SEC Filing on Google Icon
5/13/2022Renaissance Technologies LLC116,400$0.27M0.0%+27.1%0.689%Search for SEC Filing on Google Icon
5/12/2022Acadian Asset Management LLC26,582$61K0.0%-57.3%0.157%Search for SEC Filing on Google Icon
4/18/2022Taylor & Morgan Wealth Management LLC23,000$53K0.0%+91.7%0.136%Search for SEC Filing on Google Icon
2/14/2022PDT Partners LLC35,901$0.13M0.0%N/A0.213%Search for SEC Filing on Google Icon
2/10/2022Bailard Inc.42,100$0.15M0.0%N/A0.250%Search for SEC Filing on Google Icon
2/10/2022Acadian Asset Management LLC62,319$0.23M0.0%N/A0.370%Search for SEC Filing on Google Icon
2/10/2022Globeflex Capital L P233,578$0.85M0.2%-27.2%1.387%Search for SEC Filing on Google Icon
1/21/2022Taylor & Morgan Wealth Management LLC12,000$43K0.0%N/A0.071%Search for SEC Filing on Google Icon
11/15/2021Marshall Wace LLP104,980$0.42M0.0%N/A0.713%Search for SEC Filing on Google Icon
11/15/2021GSA Capital Partners LLP92,639$0.37M0.0%-38.9%0.629%Search for SEC Filing on Google Icon
11/12/2021Jump Financial LLC19,500$78K0.0%N/A0.132%Search for SEC Filing on Google Icon
9/17/2021Virtu Financial LLC19,004$80K0.0%N/A0.129%Search for SEC Filing on Google Icon
8/16/2021State Street Corp37,996$0.16M0.0%N/A0.283%Search for SEC Filing on Google Icon
8/13/2021Geode Capital Management LLC134,851$0.57M0.0%+2.4%1.006%Search for SEC Filing on Google Icon
8/13/2021Vanguard Group Inc.658,586$2.76M0.0%-1.3%4.914%Search for SEC Filing on Google Icon
8/5/2021GSA Capital Partners LLP151,532$0.64M0.1%+288.1%1.131%Search for SEC Filing on Google Icon
5/13/2021Trexquant Investment LP10,204$52K0.0%N/A0.076%Search for SEC Filing on Google Icon
5/12/2021Geode Capital Management LLC131,728$0.67M0.0%+52.2%0.983%Search for SEC Filing on Google Icon
5/10/2021GSA Capital Partners LLP39,046$0.20M0.0%N/A0.291%Search for SEC Filing on Google Icon
5/3/2021Hussman Strategic Advisors Inc.72,000$0.37M0.1%+1,957.1%0.537%Search for SEC Filing on Google Icon
4/27/2021Belvedere Trading LLC75,444$0.38M0.0%N/A0.563%Search for SEC Filing on Google Icon
2/24/2021Virtu Financial LLC14,647$65K0.0%N/A0.109%Search for SEC Filing on Google Icon
2/9/2021Bank of New York Mellon Corp16,243$72K0.0%N/A0.121%Search for SEC Filing on Google Icon
11/6/2020BlackRock Inc.191,630$0.85M0.0%-92.3%1.431%Search for SEC Filing on Google Icon
11/2/2020Hussman Strategic Advisors Inc.83,500$0.37M0.1%N/A0.623%Search for SEC Filing on Google Icon
8/12/2020Hudson Bay Capital Management LP37,037$26K0.0%N/A0.028%Search for SEC Filing on Google Icon
2/13/2020Renaissance Technologies LLC457,744$0.13M0.0%N/A0.961%Search for SEC Filing on Google Icon
1/30/2020Creative Planning103,714$30K0.0%N/A0.218%Search for SEC Filing on Google Icon
8/14/2019Vanguard Group Inc.155,963$0.17M0.0%+107.4%0.827%Search for SEC Filing on Google Icon
2/13/2019Dimensional Fund Advisors LP110,500$95K0.0%+180.1%4.859%Search for SEC Filing on Google Icon
12/13/2018Vanguard Group Inc19,932$55K0.0%-97.8%0.878%Search for SEC Filing on Google Icon
11/13/2018Dimensional Fund Advisors LP39,445$0.11M0.0%N/A1.738%Search for SEC Filing on Google Icon
8/9/2018BlackRock Inc.794,302$0.16M0.0%+1.8%34.991%Search for SEC Filing on Google Icon
8/2/2018Perkins Capital Management Inc.965,000$0.19M0.1%-3.0%42.511%Search for SEC Filing on Google Icon
2/15/2018Sabby Management LLC962,265$0.67M0.0%N/A1.513%Search for SEC Filing on Google Icon
7/12/2017Creative Planning246,811$0.34M0.0%+64,679.8%0.928%Search for SEC Filing on Google Icon
4/27/2017WealthTrust Axiom LLC140,000$0.30M0.1%N/A0.628%Search for SEC Filing on Google Icon
5/13/2016Geode Capital Management LLC81,635$0.11M0.0%No Change0.432%Search for SEC Filing on Google Icon
5/10/2016BlackRock Institutional Trust Company N.A.170,198$0.22M0.0%No Change0.901%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Biocept logo
Biocept, Inc., a molecular oncology diagnostics company, develops and commercializes proprietary circulating tumor cell and circulating cell-free tumor DNA and RNA assays utilizing a standard blood sample. Its cancer assays provide information to healthcare providers to identify oncogenic alterations that qualify a subset of cancer patients for targeted therapy at diagnosis, progression, and monitoring to identify resistance mechanisms. The company offers assays for solid tumor indications, such as breast cancer, non-small cell lung cancer (NSCLC), gastric cancer, colorectal cancer, prostate cancer, pancreaticobiliary cancer, and ovarian cancer. It also provides cerebrospinal fluid tumor cell and ctDNA and ctRNA testing services to medical oncologists, neuro-oncologists, surgical oncologists, urologists, pulmonologists, pathologists, and other physicians; clinical trial and research services to pharmaceutical companies, biopharmaceutical companies and clinical research organizations; and RT-PCR testing services for COVID-19. The company has a collaboration with CLEARED4 to develop a system for tracking and managing COVID-19 testing requirements and test results for its customers; and with Protean BioDiagnostics, Inc. to research the ability of its Target Selector molecular assay to determine EGFR status in NSCLC patients. Biocept, Inc. was incorporated in 1997 and is headquartered in San Diego, California.
Read More on Biocept

Today's Range

Now: $0.76
Low: $0.74
High: $0.77

50 Day Range

MA: $0.81
Low: $0.74
High: $0.93

52 Week Range

Now: $0.76
Low: $0.70
High: $4.25

Volume

11,357 shs

Average Volume

98,676 shs

Market Capitalization

$12.96 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.73

Who are the company insiders with the largest holdings of Biocept?

Biocept's top insider investors include:
  1. David F Hale (Director)
Learn More about top insider investors at Biocept.

Who are the major institutional investors of Biocept?

Biocept's top institutional shareholders include:
  1. Vanguard Group Inc. — 3.62%
Learn More about top institutional investors of Biocept stock.

Which institutional investors are selling Biocept stock?

Within the last quarter, BIOC stock was sold by these institutional investors:
  1. Vanguard Group Inc.